Significance of Immunotyping by CD8 and PD-L1 Immune Checkpoint Inhibitor in Epithelial Ovarian Carcinoma

被引：0
|
作者：
Srinivasan, Radhika [1 ]
Bansal, Akriti [1 ]
Rohilla, Manish [1 ]
Rai, Bhavana [1 ]
Rajwanshi, Arvind [1 ]
Suri, Vanita [1 ]
Saha, Subhas [2 ]
机构：
[1] Postgrad Inst Med Educ & Res, Chandigarh, India
[2] Postgrad Inst Med Educ & Res, Dept Obstet & Gynecol, Chandigarh, India
来源：
MODERN PATHOLOGY | 2020年 / 33卷 / SUPPL 2期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1191
引用
收藏
页码：1137 / 1139
页数：3
相关论文
共 50 条
  • [1] Significance of Immunotyping by CD8 and PD-L1 Immune Checkpoint Inhibitor in Epithelial Ovarian Carcinoma
    Srinivasan, Radhika
    Bansal, Akriti
    Rohilla, Manish
    Rai, Bhavana
    Rajwanshi, Arvind
    Suri, Vanita
    Saha, Subhas
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 1137 - 1139
  • [2] Significance of PD-L1 in Metastatic Urothelial Carcinoma Treated With Immune Checkpoint Inhibitors
    Maiorano, Brigida Anna
    Di Maio, Massimo
    Cerbone, Linda
    Maiello, Evaristo
    Procopio, Giuseppe
    Roviello, Giandomenico
    JAMA NETWORK OPEN, 2024, 7 (03) : E241215
  • [3] Correlation of CD8 infiltration and expression of its checkpoint proteins PD-L1 and PD-L2 with the stage of cervical carcinoma
    Carvalho, Maria O. O.
    Nicol, Alcina F.
    Oliveira, Nathalia S.
    Cunha, Cynthia B.
    Amaro-Filho, Sergio M.
    Russomano, Fabio B.
    Portari, Elizabeth A.
    Nuovo, Gerard J.
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 9 (10): : 10406 - 10413
  • [4] Brain metastasis PD-L1 and CD8 expression is dependent on primary tumor type and its PD-L1 and CD8 status
    Camy, Florian
    Karpathiou, Georgia
    Dumollard, Jean Marc
    Magne, Nicolas
    Perrot, Jean Luc
    Vassal, Francois
    Picot, Tiphanie
    Mobarki, Mousa
    Forest, Fabien
    Casteillo, Francois
    Hathroubi, Sirine
    Froudarakis, Marios
    Peoc'h, Michel
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (02)
  • [5] Macrocyclic Peptide Inhibitor of PD-1/PD-L1 Immune Checkpoint
    Magiera-Mularz, Katarzyna
    Kuska, Katarzyna
    Skalniak, Lukasz
    Grudnik, Przemyslaw
    Musielak, Bogdan
    Plewka, Jacek
    Kocik, Justyna
    Stec, Malgorzata
    Weglarczyk, Kazimierz
    Sala, Dominik
    Wladyka, Benedykt
    Siedlar, Maciej
    Holak, Tad A.
    Dubin, Grzegorz
    ADVANCED THERAPEUTICS, 2021, 4 (02)
  • [6] Prognostic Significance of PD-1, PD-L1 and CD8 Gene Expression Levels in Gastric Cancer
    Ito, Shuhei
    Masuda, Takaaki
    Noda, Miwa
    Hu, Qingjiang
    Shimizu, Dai
    Kuroda, Yosuke
    Eguchi, Hidetoshi
    Tobo, Taro
    Utsunomiya, Tohru
    Mimori, Koshi
    ONCOLOGY, 2020, 98 (07) : 501 - 511
  • [7] Clinical significance of PD-1, PD-L1 and CD8 gene expression levels in gastric cancer
    Ito, Shuhei
    Masuda, Takaaki
    Noda, Miwa
    Shimizu, Dai
    Wakiyama, Hiroaki
    Yoshikawa, Yukihiro
    Hu, Qingjiang
    Sato, Kuniaki
    Saito, Tomoko
    Tsuruda, Yusuke
    Kuroda, Yousuke
    Eguchi, Hidetoshi
    Mimori, Koshi
    CANCER SCIENCE, 2018, 109 : 649 - 649
  • [8] Immune Checkpoint Markers in Superficial Angiosarcomas: PD-L1, PD-1, CD8, LAG-3, and Tumor-Infiltrating Lymphocytes
    Googe, Paul B.
    Flores, Kyle
    Jenkins, Francie
    Merritt, Bradley
    Moschos, Stergios J.
    Grilley-Olson, Juneko E.
    AMERICAN JOURNAL OF DERMATOPATHOLOGY, 2021, 43 (08) : 556 - 559
  • [9] PD-L1 and CD8 Expression in Poorly Differentiated Cervical Squamous Cell Carcinoma
    Saglam, Ozlen
    Zhou, Jun-Min
    Wang, Xuefeng
    Conejo-Garcia, Jose
    MODERN PATHOLOGY, 2019, 32
  • [10] Immunohistochemical study of PD-L1 and CD8 in clear cell renal cell carcinoma
    Azueta, A.
    Marcos Gonzalez, S.
    Hoz Fernandez, J.
    Grande Gozalez, L.
    Diaz Garcia, M. P.
    Freire Salinas, J.
    Garcia Arranz, M. P.
    Rodriguez Villar, D.
    Gomez-Roman, J.
    VIRCHOWS ARCHIV, 2020, 477 : S156 - S156
12345